Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 952-957

  Fujikawa, Keita ^a   Kawakami, Atsushi ^a   Tanaka, Fumiko ^b   Iwamoto, Naoki ^a   Tamai, Mami ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

Akt; CaMKII; FLS; RA; TRAIL

Indexed keywords

BUCILLAMINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASPASE 8; DNA; ENZYME; ENZYME INHIBITOR; LEUCYLGLUTAMYLHISTIDYLASPARTASE; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PREDNISOLONE; PROTEIN KINASE B; SALAZOSULFAPYRIDINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

AGED; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CASPASE 8; CELLS, CULTURED; FEMALE; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 76649084540     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 2+/Calmodulin-dependent protein kinase II-Discovery, progress in a quarter of a Century, and perspective: Implication for learning and memory. Biol Pharm Bull 2005; 28: 1342-54.
2. COLBRAN RJ, BROWN AM: Calcium/Calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol 2004; 14: 318-27.
3. ANG ESM, ZHANG P, STEER JH et al.: Calcium/Calmodulin-dependent protein kinase is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL). J Cell Physiol 2007; 212: 787-95.
4. SEALES EC, MICOLI KJ, MCDONALD JM: Calmodulin is a crucial regulator of osteoclastic differentiation, function, and survival. J Cell Biochem 2006; 97: 45-55.
5. ZAYZAFOON M: Calcium/Calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 2006; 97: 56-70.
6. SATO K, SUEMATSU A, NAKASHIMA T et al.: Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 2006; 12: 1410-16.
7. 2+/Calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells. Circ Res 2005; 97: 541-9.
8. YAMAMOTO-YAMAGUCHI Y, OKABE-KADO J, KASUKABE T, HONMA Y: Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. Exp Hematol 2001: 29: 582-8.
9. VAN DER POUW KRAAN TCTM, VAN GAALEN FA, KASPERKOVITZ PV et al.: Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003; 48: 2132-45.
10. MIYASHITA T, KAWAKAMI A, TAMAI M et al.: Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun 2003: 312: 397-404.
11. TAMAI M, KAWAKAMAI A, TANAKA F et al.: Significant inhibition of TRAIL-mediated fibroblast-like synovial cell apoptosis by IFN-gamma through JAK/STAT pathway by translational regulation. J Lab Clin Med 2006; 147: 182-190.
12. MIYASHITA T, KAWAKAMI A, NAKASHIMA T et al.: Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Clin Exp Immunol 2004; 137: 430-6.
13. MARINO JH, COOK P, MILLER KS: Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J Immunol Methods 2003; 283: 291-306.
14. WEINMANN P, MOURA RA, CAETANO-LOPEZ JR et al.: Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy. Clin Exp Rheumatol 2007; 25: 885-7.
15. INABA M, TAKAHASHI T, KUMEDA Y et al.: Increased basal phosphorylation of mitogen-activated protein kinases and reduced responsiveness to inflammatory cytokines in neutrophils from patients with rheumatoid arthritis. Clin Exp Rheumatol 2008; 26: 52-60.
16. COURY F, FERRARO-PEYRET C, LE CAM S et al.: Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. Clin Exp Rheumatol 2008; 26: 234-9.